3rd Quarter - Termination
PRIME POLICY GROUP for QUVA PHARMA, INC.
Firm
Client
Income
$50,000
Expenses
—
Terminated
Sep 30, 2024
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Legislation and regulation impacting outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY AUSTEN KATZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.